Works matching Antiandrogens (Cancer treatment)

Results: 53

Goserelin Acetate with or without Antiandrogen or Estrogen in the Treatment of Patients with Advanced Prostate Cancer: a Multicenter, Randomized, Controlled Trial in Japan.

Published in:

Japanese Journal of Clinical Oncology, 1999, v. 29, n. 11, p. 562

By:

Kotake, Toshihiko;
Usami, Michiyuki;
Akaza, Hideyuki;
Koiso, Kenkichi;
Homma, Yukio;
Kawabe, Kazuki;
Aso, Yoshio;
Orikasa, Seiichi;
Shimazaki, Jun;
Isaka, Shigeo;
Yoshida, Osamu;
Hirao, Yoshihiko;
Okajima, Eigoro;
Naito, Seiji;
Kumazawa, Joichi;
Kanetake, Hiroshi;
Saito, Yutaka;
Ohi, Yoshitada;
Ohashi, Yasuo;
Group, the Zoladex Study

Publication type:

Article

Antiandrogen treatments in locally advanced prostate cancer: are they all the same?

Published in:

Journal of Cancer Research & Clinical Oncology, 2006, v. 132, p. 17, doi. 10.1007/s00432-006-0133-5

By:

Gillatt, David

Publication type:

Article

What implications do the tolerability profiles of antiandrogens and other commonly used prostate cancer treatments have on patient care?

Published in:

Journal of Cancer Research & Clinical Oncology, 2006, v. 132, p. 27, doi. 10.1007/s00432-006-0134-4

By:

Mason, Malcolm

Publication type:

Article

Antiandrogen Monotherapy: Recommendations for the Treatment of Prostate Cancer.

Published in:

Urologia Internationalis, 2004, v. 72, n. 2, p. 91, doi. 10.1159/000075960

By:

Sciarra, Alessandro;
Cardi, Antonio;
Di Silverio, Franco

Publication type:

Article

Definitive radiotherapy with adjuvant long-term antiandrogen treatment for locally advanced prostate cancer: health-related quality of life and hormonal changes.

Published in:

Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 3, p. 269, doi. 10.1038/pcan.2009.8

By:

Berg, A.;
Dahl, A. A.;
Bruland, Ø. S.;
Bjøro, T.;
Aanensen, M. S.;
Fosså, S. D.

Publication type:

Article

Feasibility study for the treatment of metastatic prostate cancer with the radioactive antiandrogen I-125-bicalutamide (= I-125-CASODEX).

Published in:

Journal of Labelled Compounds & Radiopharmaceuticals, 2001, v. 44, p. S670, doi. 10.1002/jlcr.25804401237

By:

Häfeli, U. O.;
Pauer, G. J.;
Miller, D. D.

Publication type:

Article

Editorial: what is the role of antiandrogen therapy in the treatment of prostate cancer?

Published in:

2006

By:

Payne, Heather

Publication type:

Editorial

Investigation of the combination of the agonist D-Trp-6-LH-RH and the antiandrogen flutamide in the treatment of dunning R-3327H prostate cancer model.

Published in:

Prostate, 1985, v. 6, n. 3, p. 219, doi. 10.1002/pros.2990060302

By:

Redding, Tommie W.;
Schally, Andrew V.

Publication type:

Article

SURVIVAL EFFECT OF PALLIATIVE RADIOTHERAPY IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER DEVELOPING OLIGO-PROGRESSION UNDER ANTIANDROGEN TREATMENT.

Published in:

Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi, 2023, v. 86, n. 2, p. 117, doi. 10.26650/IUITFD.1211556

By:

GÖKTAŞ AYDIN, Sabin;
KUTLU, Yasin;
MUĞLU, Harun;
AÇIKGÖZ, Özgür;
AYDIN, Ahmet;
BİLİCİ, Ahmet;
ÖLMEZ, Ömer Fatih;
ÜNAL, Dilek;
KARCI, Ebru;
YILDIZ, Özcan

Publication type:

Article

Comparison of Second-Generation Antiandrogens for the Treatment of Prostate Cancer.

Published in:

Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 2, p. 92

By:

Park, Seon Jo;
Yoder, Benjamin;
Li, Tammy

Publication type:

Article

Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer.

Published in:

Drug Design, Development & Therapy, 2013, v. 7, p. 875, doi. 10.2147/DDDT.S45703

By:

Semenas, Julius;
Dizeyi, Nishtman;
Persson, Jenny Liao

Publication type:

Article

Proteomic profiling of prostate cancer reveals molecular signatures under antiandrogen treatment.

Published in:

Clinical Proteomics, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12014-024-09490-9

By:

Huang, Yurun;
Yang, Guanglin;
Yao, Xinpeng;
Fang, Yue;
Lin, Qiliang;
Zhou, Menghan;
Yang, Yiping;
Meng, Qinggui;
Zhang, Qingyun;
Wang, Shan

Publication type:

Article

Focus on nilutamide: A nonsteroidal antiandrogen for treatment of advanced prostate cancer.

Published in:

Formulary, 1996, v. 31, n. 2, p. 105

By:

Chow, Moses S.S.

Publication type:

Article

THE USE OF FLUTAMIDE AS A SINGLE ANTIANDROGEN TREATMENT FOR HORMONE-REFRACTORY PROSTATE CANCER.

Published in:

2004

By:

Pitts Jr., W. R.

Publication type:

Letter

THE USE OF FLUTAMIDE AS A SINGLE ANTIANDROGEN TREATMENT FOR HORMONE-REFRACTORY PROSTATE CANCER.

Published in:

2004

By:

Fawcett, D.

Publication type:

Letter

The use of flutamide as a single antiandrogen treatment for hormone-refractory prostate cancer.

Published in:

BJU International, 2003, v. 92, n. 7, p. 695, doi. 10.1046/j.1464-410X.2003.04479.x

By:

Barqawi, A.;
Akduman, B.;
Abouelfade, Z.;
Robischon, M.;
Crawford, E. D.

Publication type:

Article

The role of antiandrogen monotherapy in the treatment of prostate cancer.

Published in:

BJU International, 2003, v. 91, n. 5, p. 455, doi. 10.1046/j.1464-410X.2003.04026.x

By:

Anderson, J.

Publication type:

Article

Radiotherapy for prevention and therapy of gynecomastia due to antiandrogen treatment in prostate cancer patients: a patterns-of-care study.

Published in:

2011

By:

Neu, Burkhard;
Sautter, Verena;
Momm, Felix;
Melcher, Ute;
Seegenschmiedt, Heinrich;
Micke, Oliver;
Sautter-Bihl, Marie-Luise

Publication type:

journal article

给药方式对亮丙瑞林微球联合抗雄激素药物治疗晚期前列腺癌的影响.

Published in:

Chinese Journal of Clinical Healthcare, 2020, v. 23, n. 5, p. 701, doi. 10.3969/J.issn.1672-6790.2020.05.031

By:

王佳;
秦侃;
邵峰;
王钰

Publication type:

Article

Differential mechanisms of bicalutamide-induced apoptosis in prostate cell lines.

Published in:

Prostate Cancer & Prostatic Diseases, 2009, v. 12, n. 1, p. 25, doi. 10.1038/pcan.2008.23

By:

St John Floyd Jr., M.;
Teahan, S. J.;
Fitzpatrick, J. M.;
Watson, R. W. G.

Publication type:

Article

Combination hormonal therapy: a reassessment within advanced prostate cancer.

Published in:

Prostate Cancer & Prostatic Diseases, 2004, v. 7, p. S2, doi. 10.1038/sj.pcan.4500741

By:

Moul, J. W.;
Chodak, G.

Publication type:

Article

Is there a role for antiandrogen monotherapy in patients with metastatic prostate cancer?

Published in:

Prostate Cancer & Prostatic Diseases, 2001, v. 4, n. 4, p. 196, doi. 10.1038/sj.pcan.4500531

By:

Kaisary, A V;
Iversen, P;
Tyrrell, C J;
Carroll, K;
Morris, T

Publication type:

Article

Will the experience with tamoxifen in breast cancer help define the role of antiandrogens in prostate cancer?

Published in:

Prostate Cancer & Prostatic Diseases, 2001, v. 4, n. 2, p. 72, doi. 10.1038/sj.pcan.4500518

By:

Chodak, G W;
Kolvenbag, G J C M

Publication type:

Article

Metabolism and hepatic toxicity of flutamide in cytochrome P450 1A2 knockout SV129 mice.

Published in:

Journal of Gastroenterology, 2006, v. 41, n. 3, p. 231, doi. 10.1007/s00535-005-1749-y

By:

Matsuzaki, Yasushi;
Nagai, Daichi;
Ichimura, Eiji;
Goda, Rika;
Tomura, Arihiro;
Doi, Mikio;
Nishikawa, Kiyohiro

Publication type:

Article

Pretreatment Lymphocyte to C-Reactive Protein Ratio: An Independent Predictor of Overall Survival in Metastatic Hormone-Naïve Prostate Cancer Patients.

Published in:

Clinical Genitourinary Cancer, 2023, v. 21, n. 6, p. e474, doi. 10.1016/j.clgc.2023.05.015

By:

Takeshi Sasaki;
Toshifumi Takahashi;
Sho Sekito;
Hideki Kanda;
Shinichiro Higashi;
Satoru Masui;
Takahiro Kojima;
Hiroshi Matsuura;
Kouhei Nishikawa;
Shusuke Akamatsu;
Yoshinaga Okugawa;
Takashi Kobayashi;
Takahiro Inoue

Publication type:

Article

Compound clamps down on prostate cancer.

Published in:: Nature Medicine, 2009, v. 15, n. 6, p. 615, doi. 10.1038/nm0609-615
Publication type:: Article

Adding antiandrogen to castration improves survival.

Published in:

Urology Times, 2005, v. 33, n. 5, p. 10

By:

Dosa, Laszlo

Publication type:

Article

Nilutamide available for advanced PCa.

Published in:: Urology Times, 1997, v. 25, n. 1, p. 45
Publication type:: Article

Effect of N-methyl deuteration on pharmacokinetics and pharmacodynamics of enzalutamide.

Published in:

Journal of Labelled Compounds & Radiopharmaceuticals, 2017, v. 60, n. 9, p. 401, doi. 10.1002/jlcr.3516

By:

Pang, Xuehai;
Peng, Lingling;
Chen, Yuanwei

Publication type:

Article

Design and Evaluation of Self-Nanoemulsifying Drug Delivery System of Flutamide.

Published in:

Journal of Young Pharmacists, 2011, v. 3, n. 1, p. 4, doi. 10.4103/0975-1483.76413

By:

Jyothi, B. Jeevana;
Sreelakshmi, K.

Publication type:

Article

Gynecomastia in Patients with Prostate Cancer: A Systematic Review.

Published in:

PLoS ONE, 2015, v. 10, n. 8, p. 1, doi. 10.1371/journal.pone.0136094

By:

Fagerlund, Anders;
Cormio, Luigi;
Palangi, Lina;
Lewin, Richard;
Santanelli di Pompeo, Fabio;
Elander, Anna;
Selvaggi, Gennaro

Publication type:

Article

Involución espontánea de meningioma. Caso clínico y revisión de la literatura.

Published in:

Neurocirugía, 2021, v. 32, n. 4, p. 188, doi. 10.1016/j.neucir.2020.06.002

By:

Ortega Martínez, Marta;
Gilete Tejero, Ignacio;
Miranda Zambrano, David;
Gestoso Ríos, Iria;
Rico Cotelo, María;
Royano Sánchez, Manuel

Publication type:

Article

Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration-resistant prostate cancer (CRPC).

Published in:

2018

By:

Pal, Sumanta Kumar;
Patel, Jaymala;
He, Miaoling;
Foulk, Brad;
Kraft, Katherine;
Smirnov, Denis A.;
Twardowski, Przemyslaw;
Kortylewski, Marcin;
Bhargava, Vipul;
Jones, Jeremy O.

Publication type:

journal article

Overview.

Published in:

Oncology, 1998, v. 55, p. 3, doi. 10.1159/000055252

By:

Ogata, E.

Publication type:

Article

Chronologically modified androgen receptor in recurrent castration-resistant prostate cancer and its therapeutic targeting.

Published in:

Science Translational Medicine, 2022, v. 14, n. 649, p. 1, doi. 10.1126/scitranslmed.abg4132

By:

Sawant, Mithila;
Mahajan, Kiran;
Renganathan, Arun;
Weimholt, Cody;
Luo, Jingqin;
Kukshal, Vandna;
Jez, Joseph M.;
Jeon, Myung Sik;
Zhang, Bo;
Li, Tiandao;
Fang, Bin;
Luo, Yunting;
Lawrence, Nicholas J.;
Lawrence, Harshani R.;
Feng, Felix Y.;
Mahajan, Nupam P.

Publication type:

Article

بررسی اثر داروی نیلوتاماید )آنتاگونیست گیرندههای آندروژنی( بر یادگیری و حافظه فضایی در دوران بلوغ موش صحرائی نر

Published in:

Arak Medical University Journal, 2019, v. 22, n. 3, p. 81

By:

زهرا سلیمی;
لطفاله خواجهپور;
فرشاد مرادپور;
احمدعلی معاضدی;
علی پورمتعبد

Publication type:

Article

Osteoporosis in men.

Published in:

Menopausal Review / Przegląd Menopauzalny, 2017, v. 16, n. 2, p. 70, doi. 10.5114/pm.2017.68596

By:

Misiorowski, Waldemar

Publication type:

Article

Bicalutamide for prostate cancer.

Published in:: American Family Physician, 1996, v. 53, n. 1, p. 399
Publication type:: Article

Tamoxifen in men: a review of adverse events.

Published in:

Andrology, 2016, v. 4, n. 5, p. 776, doi. 10.1111/andr.12197

By:

Wibowo, E.;
Pollock, P. A.;
Hollis, N.;
Wassersug, R. J.

Publication type:

Article

Androgen Receptor Signaling in the Development of Castration-Resistant Prostate Cancer.

Published in:

Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00858

By:

Feng, Qin;
He, Bin

Publication type:

Article

Dual Inhibitory Action of a Novel AKR1C3 Inhibitor on Both Full-Length AR and the Variant AR-V7 in Enzalutamide Resistant Metastatic Castration Resistant Prostate Cancer.

Published in:

Cancers, 2020, v. 12, n. 8, p. 2092, doi. 10.3390/cancers12082092

By:

Kafka, Mona;
Mayr, Fabian;
Temml, Veronika;
Möller, Gabriele;
Adamski, Jerzy;
Höfer, Julia;
Schwaiger, Stefan;
Heidegger, Isabel;
Matuszczak, Barbara;
Schuster, Daniela;
Klocker, Helmut;
Bektic, Jasmin;
Stuppner, Hermann;
Eder, Iris E.

Publication type:

Article

Prescription Practice for LH-RH Analogs and Androgen Receptor Antagonists in the Treatment of Advanced Prostate Cancer in Germany (1993–2003).

Published in:

Urologia Internationalis, 2006, v. 77, n. 4, p. 311, doi. 10.1159/000096334

By:

Rohde, Volker;
Diemer, Thorsten;
Hauck, Ekkehard;
Bestmann, Beate;
Miller, Jörg;
Schröder, Helmut;
Weidner, Wolfgang;
Katalinic, Alexander

Publication type:

Article

Enzalutamide and blocking androgen receptor in advanced prostate cancer: lessons learnt from the history of drug development of antiandrogens.

Published in:

Research & Reports in Urology, 2018, v. 10, p. 23, doi. 10.2147/RRU.S157116

By:

Ito, Yusuke;
Sadar, Marianne D

Publication type:

Article

Impact of enzalutamide on patient-related outcomes in metastatic castration-resistant prostate cancer: current perspectives.

Published in:

Research & Reports in Urology, 2016, v. 8, p. 217, doi. 10.2147/RRU.S104789

By:

Luo, Jia;
Graff, Julie N.

Publication type:

Article

A Systematic Comparison of Antiandrogens Identifies Androgen Receptor Protein Stability as an Indicator for Treatment Response.

Published in:

Life (2075-1729), 2021, v. 11, n. 9, p. 874, doi. 10.3390/life11090874

By:

Siciliano, Tiziana;
Simons, Ingo H.;
Beier, Alicia-Marie K.;
Ebersbach, Celina;
Aksoy, Cem;
Seed, Robert I.;
Stope, Matthias B.;
Thomas, Christian;
Erb, Holger H. H.

Publication type:

Article

Osteoporosis and prostate cancer.

Published in:

2003

By:

Dhillon, T.;
Waxman, J.

Publication type:

Editorial

Nonmetastatic PCa: A changing landscape: Three agents extend metastasis-free survival, address unmet need.

Published in:

Urology Times, 2019, v. 47, n. 9, p. 1

By:

Williams, Jeni

Publication type:

Article

Pilot study on the detection of antiandrogen resistance using serial diffusion-weighted imaging of bone metastases in prostate cancer.

Published in:

2016

By:

Reischauer, Carolin;
Koh, Dow‐Mu;
Froehlich, Johannes M.;
Patzwahl, René;
Binkert, Christoph A.;
Gutzeit, Andreas

Publication type:

journal article

Antiandrogens fail to block androstenedione-mediated mutated androgen receptor transactivation in human prostate cancer cells.

Published in:

International Journal of Urology, 2000, v. 7, n. 1, p. 32, doi. 10.1046/j.1442-2042.2000.00129.x

By:

Chang, Hiroshi Miyamoto

Publication type:

Article

Long‐term abiraterone withdrawal syndrome.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2018, v. 43, n. 5, p. 714, doi. 10.1111/jcpt.12693

By:

Marin, S.;
Querol, R.;
Campins, L.;
Miarons, M.;
Font, A.;
Lianes, P.

Publication type:

Article